HRP20090438T1 - Peroral formulation of dienogest and ethinylestradiol for contraception - Google Patents
Peroral formulation of dienogest and ethinylestradiol for contraceptionInfo
- Publication number
- HRP20090438T1 HRP20090438T1 HR20090438T HRP20090438T HRP20090438T1 HR P20090438 T1 HRP20090438 T1 HR P20090438T1 HR 20090438 T HR20090438 T HR 20090438T HR P20090438 T HRP20090438 T HR P20090438T HR P20090438 T1 HRP20090438 T1 HR P20090438T1
- Authority
- HR
- Croatia
- Prior art keywords
- dienogest
- ethinylestradiol
- contraception
- peroral formulation
- ethynyloestradiol
- Prior art date
Links
- 229940007694 dienogest and ethinylestradiol Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 2
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 2
- 229960003309 dienogest Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06016694A EP1886694B1 (de) | 2006-08-10 | 2006-08-10 | Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090438T1 true HRP20090438T1 (en) | 2009-09-30 |
Family
ID=37561777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090438T HRP20090438T1 (en) | 2006-08-10 | 2009-08-13 | Peroral formulation of dienogest and ethinylestradiol for contraception |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1886694B1 (el) |
| AR (1) | AR062323A1 (el) |
| AT (1) | ATE432714T1 (el) |
| CL (1) | CL2007002323A1 (el) |
| CY (1) | CY1110348T1 (el) |
| DE (1) | DE502006003892D1 (el) |
| DK (1) | DK1886694T3 (el) |
| DO (1) | DOP2007000122A (el) |
| ES (1) | ES2327665T3 (el) |
| HR (1) | HRP20090438T1 (el) |
| NO (1) | NO20091057L (el) |
| PE (1) | PE20080541A1 (el) |
| PL (1) | PL1886694T3 (el) |
| PT (1) | PT1886694E (el) |
| SI (1) | SI1886694T1 (el) |
| TW (1) | TW200817012A (el) |
| UY (1) | UY30530A1 (el) |
| WO (1) | WO2008017331A2 (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010003711B4 (de) | 2010-04-08 | 2015-04-09 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoffpartikel |
| CN115487198B (zh) * | 2022-09-20 | 2024-01-02 | 华中药业股份有限公司 | 一种快溶出度的左炔诺孕酮制剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
| DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
-
2006
- 2006-08-10 DK DK06016694T patent/DK1886694T3/da active
- 2006-08-10 PT PT06016694T patent/PT1886694E/pt unknown
- 2006-08-10 AT AT06016694T patent/ATE432714T1/de active
- 2006-08-10 PL PL06016694T patent/PL1886694T3/pl unknown
- 2006-08-10 SI SI200630376T patent/SI1886694T1/sl unknown
- 2006-08-10 DE DE502006003892T patent/DE502006003892D1/de active Active
- 2006-08-10 ES ES06016694T patent/ES2327665T3/es active Active
- 2006-08-10 EP EP06016694A patent/EP1886694B1/de active Active
-
2007
- 2007-04-26 WO PCT/EP2007/003662 patent/WO2008017331A2/de active Application Filing
- 2007-07-16 TW TW096125903A patent/TW200817012A/zh unknown
- 2007-08-07 UY UY30530A patent/UY30530A1/es unknown
- 2007-08-09 CL CL200702323A patent/CL2007002323A1/es unknown
- 2007-08-09 PE PE2007001064A patent/PE20080541A1/es not_active Application Discontinuation
- 2007-08-09 DO DO2007000122A patent/DOP2007000122A/es unknown
- 2007-08-10 AR ARP070103547A patent/AR062323A1/es not_active Application Discontinuation
-
2009
- 2009-03-09 NO NO20091057A patent/NO20091057L/no not_active Application Discontinuation
- 2009-08-13 HR HR20090438T patent/HRP20090438T1/xx unknown
- 2009-09-03 CY CY20091100928T patent/CY1110348T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20091057L (no) | 2009-03-09 |
| ATE432714T1 (de) | 2009-06-15 |
| DOP2007000122A (es) | 2008-02-15 |
| TW200817012A (en) | 2008-04-16 |
| PE20080541A1 (es) | 2008-07-10 |
| DE502006003892D1 (de) | 2009-07-16 |
| UY30530A1 (es) | 2008-03-31 |
| CY1110348T1 (el) | 2015-04-29 |
| DK1886694T3 (da) | 2009-09-28 |
| PT1886694E (pt) | 2009-08-17 |
| WO2008017331A3 (de) | 2009-01-08 |
| AR062323A1 (es) | 2008-10-29 |
| ES2327665T3 (es) | 2009-11-02 |
| SI1886694T1 (sl) | 2009-10-31 |
| PL1886694T3 (pl) | 2009-11-30 |
| CL2007002323A1 (es) | 2008-02-15 |
| EP1886694B1 (de) | 2009-06-03 |
| WO2008017331A2 (de) | 2008-02-14 |
| EP1886694A1 (de) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY169516A (en) | Pharmaceutical composition containing a tetrahydrofolic acid | |
| TW200740427A (en) | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate | |
| RS51563B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM | |
| WO2007022022A3 (en) | Volumizing agents | |
| BRPI0507342A (pt) | sólidos supersaturados estabilizados de fármacos lipofìlicos | |
| RS53554B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 2-OXO-1-PYROLIDINE DERIVATIVES | |
| HUP0400646A2 (hu) | Szteroid hormonkészítmények és előállításukra szolgáló eljárások | |
| EP1918780A3 (en) | Toner compositions | |
| CR9803A (es) | Agentes de esparcido formadores de pelicula | |
| GEP20135986B (en) | Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants | |
| SG158181A1 (en) | Improvements relating to polymeric compositions | |
| PE20070327A1 (es) | Composicion que comprende una progestina y un estrogeno | |
| ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
| CA2508824A1 (fr) | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent | |
| MX2008001645A (es) | Composiciones de fexofendina en suspension farmaceutica oral. | |
| PE20080400A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
| JP2010539153A5 (el) | ||
| HRP20090438T1 (en) | Peroral formulation of dienogest and ethinylestradiol for contraception | |
| EP2210888A3 (en) | Stable micronized candesartan cilexetil and methods for preparing thereof | |
| GT200500122A (es) | Profarmacos de esteroides con accion androgenica | |
| BRPI0412391A (pt) | formulação farmacêutica compreendendo levotiroxina sódica | |
| RS51115B (sr) | Oralne formulacije kladribina | |
| PE20010579A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos | |
| BR0116083A (pt) | Dispositivo de aplicação | |
| IL195531A0 (en) | Oral pharmaceutical composition of a poorly water-soluble active substance |